2023-07-01 2024-06-30 false Capium Accounts Production 1.1 12672982 2023-07-01 2024-06-30 12672982 bus:FullAccounts 2023-07-01 2024-06-30 12672982 bus:FRS102 2023-07-01 2024-06-30 12672982 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 12672982 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 12672982 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 12672982 2023-07-01 2024-06-30 12672982 2024-06-30 12672982 bus:RegisteredOffice 2023-07-01 2024-06-30 12672982 core:WithinOneYear 2024-06-30 12672982 core:AfterOneYear 2024-06-30 12672982 1 2023-07-01 2024-06-30 12672982 bus:Director1 2023-07-01 2024-06-30 12672982 bus:Director1 2024-06-30 12672982 bus:Director1 2022-07-01 2023-06-30 12672982 2022-07-01 12672982 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 12672982 2022-07-01 2023-06-30 12672982 2023-06-30 12672982 core:WithinOneYear 2023-06-30 12672982 core:AfterOneYear 2023-06-30 12672982 bus:EntityAccountantsOrAuditors 2022-07-01 2023-06-30 12672982 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 12672982 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 12672982 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-06-30 12672982 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 12672982 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 12672982 core:Non-currentFinancialInstruments 2024-06-30 12672982 core:Non-currentFinancialInstruments 2023-06-30 12672982 core:ShareCapital 2024-06-30 12672982 core:ShareCapital 2023-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2024-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2023-06-30 12672982 core:ShareCapitalOrdinaryShares 2023-07-01 12672982 core:ShareCapitalOrdinaryShares 2022-07-01 12672982 core:ShareCapitalOrdinaryShares 2023-07-01 2024-06-30 12672982 core:ShareCapitalOrdinaryShares 2022-07-01 2023-06-30 12672982 core:ShareCapitalOrdinaryShares 2024-06-30 12672982 core:ShareCapitalOrdinaryShares 2023-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2023-07-01 12672982 core:RetainedEarningsAccumulatedLosses 2022-07-01 12672982 core:RetainedEarningsAccumulatedLosses 2023-07-01 2024-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2022-07-01 2023-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2024-06-30 12672982 core:RetainedEarningsAccumulatedLosses 2023-06-30 12672982 dpl:Item1 2023-07-01 12672982 dpl:Item1 2024-06-30 12672982 dpl:Item1 2022-07-01 12672982 dpl:Item1 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12672982
England and Wales

 

 

 

LOVE2CARE MEDICAL LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 July 2023

End date: 30 June 2024
Director SUTTON-EVANS Tracey Louise
Registered Number 12672982
Registered Office 1 Eyre Close
GILDEA PARK
ROMFORD
RM2 6AR
1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 30 June 2024.
Principal activities
Principal activity of the company during the financial year was of ...
Director
The director who served the company throughout the year was as follows:
SUTTON-EVANS Tracey Louise
Statement of director's responsibilities
The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the director is required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.


----------------------------------
SUTTON-EVANS Tracey Louise
Director

Date approved: 18 March 2025
2
 
 
Notes
 
2024
£
  2023
£
Current assets      
Debtors 3 20,067    19,687 
Cash at bank and in hand 431    6 
20,498    19,693 
Creditors: amount falling due within one year 4 (670)   (469)
Net current assets 19,828    19,224 
 
Total assets less current liabilities 19,828    19,224 
Net assets 19,828    19,224 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 19,728    19,124 
Shareholders' funds 19,828    19,224 
 


For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 18 March 2025 and were signed by:


-------------------------------
SUTTON-EVANS Tracey Louise
Director
3
  Equity share capital   Retained Earnings   Total
£ £ £
At 01 July 2022 21,247  21,247 
Profit for the year 877  877 
Total comprehensive income for the year 877  877 
Dividends (3,000) (3,000)
Shares issued 100  100 
Total investments by and distributions to owners 100  (3,000) (2,900)
At 30 June 2023 100  19,124  19,224 
At 01 July 2023 19,124  19,124 
Profit for the year 604  604 
Total comprehensive income for the year 604  604 
Shares issued 100  100 
Total investments by and distributions to owners 100  100 
At 30 June 2024 100  19,728  19,828 
4
General Information
LOVE2CARE MEDICAL LTD is a private company, limited by shares, registered in England and Wales, registration number 12672982, registration address 1 Eyre Close, GILDEA PARK, ROMFORD, RM2 6AR.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees


Average number of employees during the year was 1 (2023 : 1).
3.

Debtors: amounts falling due within one year

2024
£
  2023
£
Accrued Income 10,000   
Other Debtors 9,666    18,166 
19,666    18,166 

3.

Debtors: amounts falling due after one year

2024
£
  2023
£
Directors Loan Accounts 401    1,521 
401    1,521 

4.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 370    219 
Accrued Expenses 300    250 
670    469 

5